» Articles » PMID: 22950420

Endothelial Cell Protein C Receptor-mediated Redistribution and Tissue-level Accumulation of Factor VIIa

Overview
Publisher Elsevier
Specialty Hematology
Date 2012 Sep 7
PMID 22950420
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies show that activated factor VII (FVIIa) binds to the endothelial cell protein C receptor (EPCR) on the vascular endothelium; however, the importance of this interaction in hemostasis or pathophysiology is unknown.

Objective: The aim of the present study was to investigate the role of the FVIIa interaction with EPCR on the endothelium in mediating FVIIa transport from the circulation to extravascular tissues.

Methods: Wild-type, EPCR-deficient or ECPR-over-expressing mice were injected with human recombinant (r)FVIIa (120 μg kg(-1) body weight) via the tail vein. At varying time intervals after rFVIIa administration, blood and various tissues were collected to measure FVIIa antigen and activity levels. Tissue sections were analyzed by immunohistochemistry for FVIIa and EPCR.

Results: The data reveal that, after intravenous (i.v.) injection, rFVIIa rapidly disappears from the blood and associates with the endothelium in an EPCR-dependent manner. Immunohistochemical analyses revealed that the association of FVIIa with the endothelium was maximal at 30 min and thereafter progressively declined. The FVIIa association with the endothelium was undetectable at time points exceeding 24 h post-FVIIa administration. The levels of rFVIIa accumulated in tissue correlate with expression levels of EPCR in mice and FVIIa associated with tissues remained functionally active for periods of at least 7 days.

Conclusions: The observation that an EPCR-dependent association of FVIIa with the endothelium is most pronounced soon after rFVIIa administration and subsequently declines temporally, combined with the retention of functionally active FVIIa in tissue homogenates for extended periods, indicates that FVIIa binding to EPCR on the endothelium facilitates the transport of FVIIa from circulation to extravascular tissues where TF resides.

Citing Articles

Recombinant factor VIIa: new insights into the mechanism of action through product innovation.

Escobar M, Hoffman M, Castaman G, Hermans C, Mahlangu J, Oldenburg J Res Pract Thromb Haemost. 2025; 9(1):102670.

PMID: 39990097 PMC: 11847032. DOI: 10.1016/j.rpth.2024.102670.


Endothelial Protein C Receptor and Its Impact on Rheumatic Disease.

OHehir Z, Lynch T, ONeill S, March L, Xue M J Clin Med. 2024; 13(7).

PMID: 38610795 PMC: 11012567. DOI: 10.3390/jcm13072030.


The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.

Escobar M, Castaman G, Boix S, Callaghan M, Moerloose P, Ducore J Haemophilia. 2021; 27(6):921-931.

PMID: 34636112 PMC: 9292935. DOI: 10.1111/hae.14419.


Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.

Ten Cate H, Guzik T, Eikelboom J, Spronk H Cardiovasc Res. 2020; 117(9):2030-2044.

PMID: 32931586 PMC: 8318102. DOI: 10.1093/cvr/cvaa263.


Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.

Keshava S, Pendurthi U, Esmon C, Rao L J Thromb Haemost. 2020; 18(8):1911-1921.

PMID: 32359012 PMC: 7415704. DOI: 10.1111/jth.14881.


References
1.
Gleeson E, ODonnell J, Preston R . The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling. Cell Mol Life Sci. 2011; 69(5):717-26. PMC: 11115159. DOI: 10.1007/s00018-011-0825-0. View

2.
Almus F, Rao L, Fleck R, RAPAPORT S . Properties of factor VIIa/tissue factor complexes in an umbilical vein model. Blood. 1990; 76(2):354-60. View

3.
Young G, McDaniel M, Nugent D . Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors. Haemophilia. 2005; 11(3):203-7. DOI: 10.1111/j.1365-2516.2005.01096.x. View

4.
Preston R, Ajzner E, Razzari C, Karageorgi S, Dua S, Dahlback B . Multifunctional specificity of the protein C/activated protein C Gla domain. J Biol Chem. 2006; 281(39):28850-7. DOI: 10.1074/jbc.M604966200. View

5.
Nayak R, Sen P, Ghosh S, Gopalakrishnan R, Esmon C, Pendurthi U . Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications. Blood. 2009; 114(9):1974-86. PMC: 2738580. DOI: 10.1182/blood-2009-03-208900. View